<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2954-3835</journal-id>
<journal-title><![CDATA[Cardiovascular and metabolic science]]></journal-title>
<abbrev-journal-title><![CDATA[Cardiovasc. metab. sci]]></abbrev-journal-title>
<issn>2954-3835</issn>
<publisher>
<publisher-name><![CDATA[Asociación Nacional de Cardiólogos de México A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2954-38352025000200095</article-id>
<article-id pub-id-type="doi">10.35366/120544</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Atherogenic risk profiles and cardiovascular risk assessment in hospitalized patients with type 2 diabetes]]></article-title>
<article-title xml:lang="es"><![CDATA[Perfiles de riesgo aterogénico y evaluación del riesgo cardiovascular en pacientes hospitalizados con diabetes tipo 2]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chale-De la Cruz]]></surname>
<given-names><![CDATA[Alejandro Ernesto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quiroz-Gomez]]></surname>
<given-names><![CDATA[Sergio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Landero-Jiménez]]></surname>
<given-names><![CDATA[Rubén]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guzmán-Priego]]></surname>
<given-names><![CDATA[Crystell Guadalupe]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez-Sastré]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Juárez Autónoma de Tabasco División Académica de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Villahermosa Tabasco]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Juárez Autónoma de Tabasco División Académica de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Villahermosa Tabasco]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>36</volume>
<numero>2</numero>
<fpage>95</fpage>
<lpage>103</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2954-38352025000200095&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2954-38352025000200095&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2954-38352025000200095&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Cardiovascular diseases are the leading cause of morbidity and mortality among individuals with type two diabetes mellitus, affecting adults aged 20 to 79 years.  Objective:  The study aims to correlate atherogenic risk factors with the duration of diabetes diagnosis to determine the cardiovascular risk of patients in a hospital ward.  Material and methods:  This observational, correlational, and cross-sectional study was conducted at the Center of Medical Specialties of the Instituto de Seguridad Social del Estado de Tabasco from January to June 2024. A representative sample of three hundred forty-three patients was selected from a population of 3,193, using a 95% confidence level and a five percent margin of error. The Framingham cardiovascular risk prediction Table was adapted, achieving validation with a Cronbach&#8217;s alpha coefficient of 0.770.  Results:  Among the three hundred forty-three patients evaluated, 39 (11.4%) were found to have a high risk of experiencing a cardiovascular event within the next 10 years. A significant positive correlation was found between cardiovascular risk and the duration since the diagnosis of type 2 diabetes, with a p-value of 0.003.  Conclusion:  The findings confirm that the duration of diabetes is a significant determinant of cardiovascular risk in hospitalized patients.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  Las enfermedades cardiovasculares son la causa principal de morbimortalidad en personas con diabetes mellitus tipo 2, afectando a adultos entre 20 y 79 años.  Objetivo:  El estudio busca una correlación entre los factores de riesgo aterogénicos con el tiempo de diagnóstico de diabetes para determinar el riesgo cardiovascular que tienen los pacientes en una sala de hospitalización.  Material y métodos:  Este estudio observacional, correlacional y transversal se llevó a cabo en el Centro de Especialidades Médicas del Instituto de Seguridad Social del Estado de Tabasco, desde enero hasta junio de 2024. Se seleccionó una muestra representativa de 343 pacientes de una población total de 3,193, utilizando un nivel de confianza del 95% y un margen de error del 5%. Se adaptó la Tabla de predicción de riesgo cardiovascular de Framingham, logrando una validación con un coeficiente de Alpha de Cronbach de 0.770.  Resultados:  Entre los 343 pacientes evaluados, la distribución del riesgo cardiovascular fue de 39 (11.4%) pacientes que presentan un riesgo alto de experimentar un evento cardiovascular en los próximos 10 años. Se encontró una correlación positiva significativa entre el riesgo cardiovascular y el tiempo desde el diagnóstico de DM2 con un valor de p = 0.003.  Conclusión:  Los hallazgos confirman que la duración de la diabetes es un determinante significativo para el riesgo cardiovascular en los pacientes hospitalizados.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[cardiology]]></kwd>
<kwd lng="en"><![CDATA[atherogenic]]></kwd>
<kwd lng="en"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[cardiovascular risk]]></kwd>
<kwd lng="es"><![CDATA[cardiología]]></kwd>
<kwd lng="es"><![CDATA[aterogénica]]></kwd>
<kwd lng="es"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="es"><![CDATA[riesgo cardiovascular]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<source><![CDATA[IDF Diabetes Atlas]]></source>
<year></year>
<publisher-name><![CDATA[Diabetesatlas.org]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística y Geografía (INEGI)</collab>
<source><![CDATA[]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Introduction: standards of medical care in diabetes-2022]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2022</year>
<volume>45</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S1-2</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bacuilima]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cross-sectional study: cardiovascular risk in type II diabetes mellitus according to UKPDS score in patients from José Carrasco Arteaga Hospital]]></article-title>
<source><![CDATA[Rev Med HJCA]]></source>
<year>2020</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>178-87</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosas-Peralta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arizmendi-Uribe]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Borrayo-Sánchez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What do adults die from in Mexico?]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc]]></source>
<year>2017</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>98-103</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Russo]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Grande-Ratti]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Burgos]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Molaro]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Bonella]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of diabetes, epidemiological characteristics, and vascular complications]]></article-title>
<source><![CDATA[Arch Cardiol Mex]]></source>
<year>2023</year>
<volume>93</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>93-102</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>National Institute of Statistics and Geography (INEGI)</collab>
<source><![CDATA[Statistics of registered deaths (EDR) 2023]]></source>
<year>2024</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Pradeep]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Dyslipidemia. MSD Manual Professional Version]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Millán]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pintó]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zúñiga]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rubiés-Prat]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pallardo]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipoprotein ratios: physiological significance and clinical utility of atherogenic indices in cardiovascular prevention]]></article-title>
<source><![CDATA[Clin Investig Arterioscler]]></source>
<year>2010</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-32</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>Press Room</collab>
<source><![CDATA[Press release. Instituto Nacional de Estadística y Geografía (INEGI)]]></source>
<year>2024</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística y Geografía (INEGI)</collab>
<source><![CDATA[Estadísticas de defunciones registradas (EDR) de enero a junio de 2023 (preliminar)]]></source>
<year>2024</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alonso-Martínez]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrer-Arrocha]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Carballo-Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atherosclerotic risk factors in relatives of type 2 diabetic patients]]></article-title>
<source><![CDATA[Rev Cuba Investig Bioméd]]></source>
<year>2014</year>
<volume>33</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>367-76</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfonso]]></surname>
<given-names><![CDATA[GJ.]]></given-names>
</name>
</person-group>
<source><![CDATA[Obesity. Epidemic of the 21st century. Type 2 diabetes mellitus and obesity]]></source>
<year>2008</year>
<page-range>208</page-range><publisher-name><![CDATA[Editorial Científico Técnica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Scull]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity and its clinic-metabolic consequences]]></article-title>
<source><![CDATA[Rev Cub Endocrinol]]></source>
<year>2004</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Sedentary lifestyle</collab>
<source><![CDATA[Sedentarism, diet, obesity, alcohol, and tobacco consumption as risk factors for the development of type 2 diabetes]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez-Cosmea]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular risk tables: a critical review]]></article-title>
<source><![CDATA[Medifam]]></source>
<year>2001</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>20-51</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<collab>Gobierno de México</collab>
<source><![CDATA[Informe sobre la situación de salud y el avance de la Estrategia Nacional para la Prevención y Control de Enfermedades Crónicas No Transmisibles, Primer trimestre 2024]]></source>
<year>2024</year>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Aroda]]></surname>
<given-names><![CDATA[VR]]></given-names>
</name>
<name>
<surname><![CDATA[Collins]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Gabbay]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Maruthur]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2022</year>
<volume>45</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2753-86</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vega-Jiménez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Verano-Gómez]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-López]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Labrada-González]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Garrido]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Espinosa-Pire]]></surname>
<given-names><![CDATA[LN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardioatherogenic factors and cardiovascular risk in hospitalized type 2 diabetics]]></article-title>
<source><![CDATA[Rev Cuba Med Mil]]></source>
<year>2018</year>
<volume>47</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iván]]></surname>
<given-names><![CDATA[ZFT]]></given-names>
</name>
<name>
<surname><![CDATA[Berenica]]></surname>
<given-names><![CDATA[PMB]]></given-names>
</name>
<name>
<surname><![CDATA[Keren]]></surname>
<given-names><![CDATA[FMR]]></given-names>
</name>
<name>
<surname><![CDATA[Gloria]]></surname>
<given-names><![CDATA[NF]]></given-names>
</name>
<name>
<surname><![CDATA[Juan]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Level of knowledge of cardiovascular risk factors in patients with type 2 diabetes mellitus]]></article-title>
<source><![CDATA[Rev. Esc. Med. Dr. J. Sierra]]></source>
<year>2022</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>49</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Díaz]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[García-Ugalde]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular risk factors associated with diabetic foot]]></article-title>
<source><![CDATA[Rev Méd Sinergia]]></source>
<year>2019</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>4-20</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva-Saboya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Risk factors associated with type 2 diabetes mellitus in adults treated at IPRESS I-3 Belén 2021]]></source>
<year>2021</year>
<publisher-name><![CDATA[Univ Cient Peru]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zamora-Fung]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Blanc-Márquez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García-Gázquez]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Borrego-Moreno]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Fundora-Gonzalez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimation of cardiovascular risk in patients with type 2 diabetes mellitus at a medical office]]></article-title>
<source><![CDATA[Univ Med Pinareña]]></source>
<year>2020</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zalapa-Farias]]></surname>
<given-names><![CDATA[TI]]></given-names>
</name>
<name>
<surname><![CDATA[Perez-Martinez]]></surname>
<given-names><![CDATA[BB]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandez-Mancilla]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Floriano]]></surname>
<given-names><![CDATA[GN]]></given-names>
</name>
<name>
<surname><![CDATA[Romo-Salazar]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Level of knowledge of cardiovascular risk factors in patients with type 2 diabetes mellitus]]></article-title>
<source><![CDATA[Rev Esc Med Dr. J. Sierra]]></source>
<year>2022</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>49-54</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poll-Cabrera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hierrezuelo-Rojas]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Soto-Bell]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Begó-Godínez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Velazquez-Cedeño]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta-Montero]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimación del riesgo cardiovascular en pacientes con diabetes mellitus tipo 2]]></article-title>
<source><![CDATA[Arch Méd Camagüey]]></source>
<year>2024</year>
<volume>28</volume>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garza-López]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Silva-Ruiz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Pérez]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular risk estimation in Mexican patients with type 2 diabetes mellitus]]></article-title>
<source><![CDATA[Rev Investig Clín]]></source>
<year>2024</year>
<volume>76</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>226-36</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
